Find a Trial

Trial Summary


Protocol No.NEUR-NCI-NRG-BN007
StatusOPEN TO ACCRUAL
Principal InvestigatorNevel, Kathryn
ScopeNational
PhasePhase II/III
Age GroupAdult
TitleA RANDOMIZED PHASE II/III OPEN-LABEL STUDY OF IPILIMUMAB AND NIVOLUMAB VERSUS TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MGMT (TUMOR O-6-METHYLGUANINE DNA METHYLTRANSFERASE) UNMETHYLATED GLIOBLASTOMA.
Applicable Disease SitesBrain and Nervous System
Participating InstitutionsIndiana University (IU)
    Treatment TypeTreatment
    ContactPhone: (317) 278-5632
    Email: iutrials@iu.edu